Epigenomics Licenses Health Discovery's SVM Technology for DNA Methylation Analysis | GenomeWeb
NEW YORK (GenomeWeb News) - Health Discovery Corporation said today that Epigenomics has taken a non-exclusive worldwide license to its support vector machine technology for use in DNA methylation analysis.
 
HDC’s SVM technology is a machine-learning approach for classifying high-dimensional data. Epigenomics will use the technology in its biomarker service and collaboration business to help measure the differences in DNA methylation patterns between healthy and diseased tissues.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.